Digital technology is already changing healthcare, and when it comes to respiratory care, Teva are at the forefront. We are committed to a future where devices, technology and services are no longer an afterthought. Welcome to respiratory_care v2.0.
At Teva, we envision an entire connected system where patient, provider and caregiver are united through never-before-seen accurate data on inhaler use, enabling informed communication and clinical decision-making to transform respiratory care.
As the social and economic burden of asthma and COPD continues to rise on a global scale, there is a desperate need for innovative disease management solutions. This impending future for respiratory care represents our biggest challenges, yet our greatest opportunities.
This year, the European Respiratory Society (ERS) International Congress saw the launch of respiratory_care v2.0—Teva’s innovative technology that is pioneering the future of respiratory care.
Over 1000 delegates immersed themselves in a world of respiratory_care v2.0 with activities at the Teva booth. Our interactive respiratory consultation revealed the power of connected data, convincing 57% of HCPs to change their next-step treatment decisions. Meanwhile, many participants in our connected data card game requested a deck for their own clinic! Take a look at the key findings from delegates’ answers to thought-provoking questions on the future of connected respiratory care…
Away from the booth, 480 delegates attended a Teva-sponsored symposium on ‘How new approaches and technologies will transform respiratory care’. Chaired by Peter Barnes, the symposium offered a unique opportunity to explore how health technologies in respiratory care are working now and how they will tackle unmet patient needs in the future.
How can the contrasting worlds of healthcare and technology collaborate to create truly effective digital health solutions, to ultimately benefit the entire healthcare system?
Explore all of this, and much more at www.respiratorycarev2.com.